Blog

What’s in a name? Plenty when it’s about stem cells – Business Line


Business Line

What's in a name? Plenty when it's about stem cells
Business Line
Closer home, April also saw the Union Health Ministry come out with a draft notification clarifying the definition of stem cells or cell-based products as drugs. It would be classified a drug if the cells were processed, altered or put through “more …
Stem Cell Training Signs Agreement to Provide Onsite Regenerative Medicine Training WorldwideDigital Journal


Global Human Embryonic Stem Cell Market Size 2018 Share- (StemCells, Asterias Biotherapeutics, ReNeuron Limited)satPRnews (press release)
Global Fetal Stem Cells Market Size 2018 Share- (STEMCELL Technologies, Axol Bio, Thermo Fisher Scientific)The Mobile Herald
Pharmaceuticals News
all 14 news articles »

2018-04-27 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.